May 2023 – We are thrilled to announce that SELENA+ has successfully attained regulatory approval from the Ministry of Health & Prevention, United Arab Emirates (UAE). market
At nearly 19%, UAE has one of the world’s highest rates of diabetes. With diabetes comes complications such as diabetes retinopathy (DR) which left untreated can lead to blindness. It is well-documented that mass screening and early detection is key to managing DR. Addressing diabetes-related problems places a heavy burden on the nation’s healthcare system and resources, thus a new screening-detection approach needs to take place.
SELENA+ is a cutting-edge AI solution designed to revolutionize the way you detect eye and systemic diseases using the fundus image. With this approval as an initial springboard, EyRIS is now ready to introduce the entire suite of EyRIS solutions to the UAE, and eventually the GCC region.
Please direct all queries related to this article to Marketing at firstname.lastname@example.org
Comments are closed.